Syneos Health DSO Ratio 2011-2026 | SYNH

Annual DSO Ratio Syneos Health

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	111	102	104	139	87.3	77.7	76.9	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
139	76.9	99.7

Quarterly DSO Ratio Syneos Health

2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	-	-	-	-	-	-	-	-	-	30.7	-	59.9	58.6	59.2	-	59.6	62	59.2	78.2	71.3	96.9	47.7	-	43	45.9	40.8	-	41.3	42.8	42.6	-	39.8	41.6	44.5	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
96.9	30.7	53.3

DSO Ratio of other stocks in the Diagnostics research industry

Issuer	DSO Ratio	Price	% 24h	Market Cap	Country
Akumin AKU	57.4	-	-17.87 %	$ 25.9 M	Canada
Centogene N.V. CNTG	145	-	-6.23 %	$ 30.6 M	Germany
Co-Diagnostics CODX	94.7	$ 1.63	-1.21 %	$ 2.17 M	USA
Agilent Technologies A	63.8	$ 114.87	-0.65 %	$ 34.9 B	USA
Accelerate Diagnostics AXDX	291	-	-61.36 %	$ 2.46 M	USA
Chembio Diagnostics CEMI	66.3	-	0.22 %	$ 16.8 M	USA
Aspira Women's Health AWH	1.17 K	-	-6.19 %	$ 10.5 M	USA
Biocept BIOC	112	-	-13.05 %	$ 7.29 M	USA
Castle Biosciences CSTL	49.2	$ 24.7	-1.12 %	$ 686 M	USA
Enzo Biochem ENZ	50.3	-	-8.98 %	$ 14.8 K	USA
CareDx, Inc CDNA	51.5	$ 21.91	0.27 %	$ 1.17 B	USA
Illumina ILMN	61.3	$ 126.92	-1.24 %	$ 20.2 B	USA
Oxford Immunotec Global PLC OXFD	90.8	-	-	$ 562 M	Britain
DermTech DMTK	80.6	-	-11.32 %	$ 2.94 M	USA
Exact Sciences Corporation EXAS	30.8	-	-	$ 19.8 B	USA
Fulgent Genetics FLGT	77.4	$ 15.3	-1.92 %	$ 463 M	USA
HTG Molecular Diagnostics HTGM	101	-	-20.0 %	$ 1.06 M	USA
Lantheus Holdings LNTH	80.5	$ 83.55	-0.67 %	$ 5.64 B	USA
Global Cord Blood Corporation CO	112	-	-	$ 399 M	China
Fluidigm Corporation FLDM	67.2	-	1.08 %	$ 308 M	USA
Genetic Technologies Limited GENE	11.7 K	-	-	$ 7.1 B	Australia
Genetron Holdings Limited GTH	122	-	0.12 %	$ 80.1 M	China
Charles River Laboratories International CRL	65	$ 166.79	-2.59 %	$ 8.27 B	USA
National Research Corporation NRC	29.4	$ 16.84	-1.58 %	$ 377 M	USA
PRA Health Sciences, Inc. PRAH	98.1	-	-	$ 10.7 B	USA
Guardant Health GH	46.1	$ 83.09	-6.11 %	$ 10.4 B	USA
Precipio PRPO	21.1	$ 31.75	3.42 %	$ 51 M	USA
Personalis PSNL	55.8	$ 5.5	-7.72 %	$ 326 M	USA
Heska Corporation HSKA	40.8	-	-	$ 1.31 B	USA
Interpace Biosciences IDXG	66.9	$ 1.93	-	$ 8.54 M	USA
Senseonics Holdings SENS	10.3	$ 7.18	-1.24 %	$ 300 M	USA
Medpace Holdings MEDP	50.4	$ 409.65	-2.78 %	$ 11.8 B	USA
QIAGEN N.V. QGEN	30.8	-	-	$ 10.6 B	Niderland
Motus GI Holdings MOTS	77.2	-	-34.28 %	$ 263 K	Israel
Biomerica BMRA	57.7	$ 2.19	0.46 %	$ 5.03 M	USA
Thermo Fisher Scientific TMO	70	$ 470.22	0.47 %	$ 177 B	USA
ICON Public Limited Company ICLR	68.5	$ 102.49	-0.7 %	$ 8.45 B	Irlanda
Laboratory Corporation of America Holdings LH	52.9	$ 259.57	-1.47 %	$ 21.6 B	USA
Trinity Biotech plc TRIB	87.2	$ 0.61	-4.93 %	$ 61.9 M	Irlanda
Neogen Corporation NEOG	66.6	$ 9.34	-1.16 %	$ 2.03 B	USA
Twist Bioscience Corporation TWST	44.5	$ 59.15	-3.03 %	$ 3.54 B	USA
NeoGenomics NEO	77.7	$ 9.02	4.76 %	$ 1.16 B	USA
Myriad Genetics MYGN	52.3	$ 4.84	0.21 %	$ 448 M	USA
Natera NTRA	81.5	$ 200.17	-2.06 %	$ 19.7 B	USA
Quest Diagnostics Incorporated DGX	44.9	$ 195.05	-0.8 %	$ 21.7 B	USA
Invitae Corporation NVTA	242	-	-	$ 21.2 M	USA
OpGen OPGN	4.66	-	-16.95 %	$ 1.54 M	USA